Targeting Bcl-2 protein in treatment of melanoma still requires further clarifications.
Pisano
M
M
Baldinu
P
P
Sini
M C
MC
Ascierto
P A
PA
Tanda
F
F
Palmieri
G
G
D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D013873:Thionucleotides / Q000494:pharmacology*
D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D013873:Thionucleotides; C408162:oblimersen